Sandra Milligan - Insider Trading & Ownership

Location
2000 Galloping Hill Road, Kenilworth, NJ
Summary
The estimated net worth of Sandra Milligan is at least $940K dollars as of August 20, 2025. Sandra Milligan is the Head of Research & Development of Organon & Co. and owns shares of Organon & Co. (OGN) stock worth about $723K. Sandra Milligan is the Director of Gossamer Bio, Inc. and owns shares of Gossamer Bio, Inc. (GOSS) stock worth about $111K. Sandra Milligan is the Interim CEO of Aspira Women's Health Inc. and owns shares of Aspira Women's Health Inc. (AWHL) stock worth about $106K.
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Sandra Milligan

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
OGN Organon & Co. Head of Research & Development $723K May 4, 2023
GOSS Gossamer Bio, Inc. Director $111K +$50K +81.4% Aug 19, 2025
AWHL Aspira Women's Health Inc. Interim CEO $106K Dec 31, 2024
SYRE Spyre Therapeutics, Inc. Director May 29, 2025

Insider Transactions Reported by Sandra Milligan:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.